Boots Healthcare International

From Powerbase
Jump to: navigation, search

In October 2005 Boots agreed to sell its over-the-counter medicines business, Boots Healthcare International, which markets brands such as Clearasil, Nurofen, Optrex, E45 and Strepsils, to the Anglo-Dutch household products company Reckitt Benckiser for £1.936 billion. The disposal was completed on 31 January 2006.[1]


  1. Reckitt Benckiser 07/10/2005 Acquisition of Boots Healthcare International Latest News, accessed 1 December 2007